Rankings
▼
Calendar
ANIK FY 2011 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$204M
FY 2011 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$65M
+16.6% YoY
Gross Profit
$38M
58.7% margin
Operating Income
$14M
21.6% margin
Net Income
$8M
13.1% margin
EPS (Diluted)
$0.62
Cash Flow
Operating Cash Flow
$10M
Free Cash Flow
$9M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$133M
Total Liabilities
$38M
Stockholders' Equity
$95M
Cash & Equivalents
$36M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$65M
$56M
+16.6%
Gross Profit
$38M
$32M
+19.7%
Operating Income
$14M
$8M
+85.3%
Net Income
$8M
$4M
+96.2%
← FY 2010
All Quarters
FY 2012 →